dIncreasing antibiotic resistance in pathogenic bacteria necessitates the development of new medication strategies. Interfering with the metabolic network of the pathogen can provide novel drug targets but simultaneously requires a deeper and more detailed organism-specific understanding of the metabolism, which is often surprisingly sparse. In light of this, we reconstructed a genome-scale metabolic model of the pathogen Enterococcus faecalis V583. The manually curated metabolic network comprises 642 metabolites and 706 reactions. We experimentally determined metabolic profiles of E. faecalis grown in chemically defined medium in an anaerobic chemostat setup at different dilution rates and calculated the net uptake and product fluxes to constrain the model. We computed growth-associated energy and maintenance parameters and studied flux distributions through the metabolic network. Amino acid auxotrophies were identified experimentally for model validation and revealed seven essential amino acids. In addition, the important metabolic hub of glutamine/glutamate was altered by constructing a glutamine synthetase knockout mutant. The metabolic profile showed a slight shift in the fermentation pattern toward ethanol production and increased uptake rates of multiple amino acids, especially L-glutamine and L-glutamate. The model was used to understand the altered flux distributions in the mutant and provided an explanation for the experimentally observed redirection of the metabolic flux. We further highlighted the importance of gene-regulatory effects on the redirection of the metabolic fluxes upon perturbation. The genome-scale metabolic model presented here includes gene-protein-reaction associations, allowing a further use for biotechnological applications, for studying essential genes, proteins, or reactions, and the search for novel drug targets.
Enterococcus faecalis plays an important role in both biotechnology and medicine (1, 2). Some strains are used in the dairy industry for food fermentation and flavor production. At the same time, other strains play an increasingly important role as pathogens, especially in hospital-acquired infections (1). E. faecalis strains show multiple antibiotic resistances and are therefore the cause of serious complications. Alternative strategies for combating multiple resistant bacteria such as E. faecalis are urgently needed. Targeting vulnerable points in the bacterial metabolism could offer such an alternative route and has been discussed as a promising strategy (3, 4). However, surprisingly little is known about the detailed metabolism of E. faecalis, and it is therefore mandatory to explore this in a more elaborate fashion than previously reported.E. faecalis shows a high stress tolerance and is adapted to a variety of different native environments ranging from soil up to human or animal digestive tracts (1, 2). This environmental variability requires a highly flexible metabolic system to quickly adapt to diverse and changing environmental conditions. Therefore, strategies...